test

Troy Wuertz

@Ikarian Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$717.154MTotal holdings121
Assets growth rate24.93%Assets growth rate (2-Q avg)-6.06%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Ikarian Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 121 positions.

Assets under management

The assets under management (AUM) of Ikarian Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 717.154M in assets, with a quarterly growth rate of 24.93% and a 2-quarter average growth rate of -6.06%. The portfolio is managed by Troy Wuertz, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PRAXPraxis Precision Medicines I
Recent Activity
Exited
0%
$29.883M↑ Call
7,225 shares@ $4136.0 avg price
NBIXNeurocrine Biosciences Inc
Recent Activity
Exited
0%
$19.274M↑ Call
41,000 shares@ $470.1 avg price
AREAlexandria Real Estate Eq In
Recent Activity
Exited
0%
$8.574M↓ Put
733 shares@ $11697.0 avg price
AZNAstrazeneca Plc
Recent Activity
Exited
0%
$8.517M↑ Call
1,092 shares@ $7799.0 avg price
VKTXViking Therapeutics Inc
Recent Activity
Exited
0%
$7.329M
138,262 shares@ $53.02 avg price
CORTCorcept Therapeutics Inc
Recent Activity
Exited
0%
$6.043M↑ Call
1,860 shares@ $3249.0 avg price
GTHXG1 Therapeutics Inc
Recent Activity
Exited
0%
$5.726M↑ Call
25,112 shares@ $228.0 avg price
ARQTArcutis Biotherapeutics Inc
Recent Activity
Exited
0%
$4.554M
489,642 shares@ $9.31 avg price
CYBNCybin Inc
Recent Activity
Exited
0%
$3.781M
13.953M shares@ $0.28 avg price
ANVSAnnovis Bio Inc
Recent Activity
Exited
0%
$3.476M↑ Call
6,034 shares@ $576.0 avg price